13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001214659-23-011268
Total Value
$718.7M
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 2,618,300 | $238.5M | 33.19% |
| 2 | VERONA PHARMA PLC | 925050106 | 2,468,000 | $52.2M | 7.26% |
| 3 | CYMABAY THERAPEUTICS INC | 23257D103 | 4,570,918 | $50.1M | 6.96% |
| 4 | ARCUS BIOSCIENCES INC | RCUS | 1,968,000 | $40.0M | 5.56% |
| 5 | ROIVANT SCIENCES LTD | ROIV | 3,904,000 | $39.4M | 5.48% |
| 6 | MIRATI THERAPEUTICS INC | 60468T105 | 750,000 | $27.1M | 3.77% |
| 7 | CELLDEX THERAPEUTICS INC NEW | CLDX | 759,898 | $25.8M | 3.59% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 923,000 | $22.0M | 3.06% |
| 9 | BRIDGEBIO PHARMA INC | BBIO | 1,219,200 | $21.0M | 2.92% |
| 10 | 89BIO INC | 282559103 | 1,066,784 | $20.2M | 2.81% |
| 11 | DISC MEDICINE INC | IRON | 415,000 | $18.4M | 2.56% |
| 12 | VIR BIOTECHNOLOGY INC | VIR | 650,100 | $15.9M | 2.22% |
| 13 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,368,587 | $15.5M | 2.16% |
| 14 | TANDEM DIABETES CARE INC | TNDM | 474,929 | $11.7M | 1.62% |
| 15 | AEROVATE THERAPEUTICS INC | 008064107 | 621,712 | $10.7M | 1.48% |
| 16 | ITEOS THERAPEUTICS INC | 46565G104 | 596,000 | $7.9M | 1.10% |
| 17 | DYNE THERAPEUTICS INC | DYN | 692,945 | $7.8M | 1.08% |
| 18 | INSMED INC | INSM | 367,000 | $7.7M | 1.08% |
| 19 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 750,000 | $7.7M | 1.07% |
| 20 | TRAVERE THERAPEUTICS INC | TVTX | 495,000 | $7.6M | 1.06% |
| 21 | GERON CORP | GERN | 2,278,000 | $7.3M | 1.02% |
| 22 | XILIO THERAPEUTICS INC | XLO | 2,425,000 | $6.4M | 0.88% |
| 23 | AN2 THERAPEUTICS INC | ANTX | 720,900 | $6.1M | 0.85% |
| 24 | JASPER THERAPEUTICS INC | JSPRW | 4,468,114 | $6.1M | 0.85% |
| 25 | VIKING THERAPEUTICS INC | VKTX | 375,000 | $6.1M | 0.85% |
| 26 | ANNEXON INC | ANNX | 1,660,000 | $5.8M | 0.81% |
| 27 | GLYCOMIMETICS INC | 38000Q102 | 3,000,000 | $5.2M | 0.73% |
| 28 | GOSSAMER BIO INC | GOSS | 3,958,069 | $4.7M | 0.66% |
| 29 | LEXICON PHARMACEUTICALS INC | LXRX | 1,923,076 | $4.4M | 0.61% |
| 30 | STRUCTURE THERAPEUTICS INC | GPCR | 75,000 | $3.1M | 0.43% |
| 31 | PMV PHARMACEUTICALS INC | PMVP | 470,000 | $2.9M | 0.41% |
| 32 | CENTESSA PHARMACEUTICALS PLC | CNTA | 411,928 | $2.5M | 0.35% |
| 33 | ORIC PHARMACEUTICALS INC | ORIC | 277,000 | $2.1M | 0.30% |
| 34 | STOKE THERAPEUTICS INC | STOK | 185,669 | $2.0M | 0.27% |
| 35 | IVERIC BIO INC | 46583P102 | 50,000 | $2.0M | 0.27% |
| 36 | HEPION PHARMACEUTICALS INC | CTRVP | 155,000 | $1.6M | 0.23% |
| 37 | VERA THERAPEUTICS INC | VERA | 70,000 | $1.1M | 0.16% |
| 38 | PIERIS PHARMACEUTICALS INC | 720795103 | 6,600,000 | $1.1M | 0.15% |
| 39 | MAGENTA THERAPEUTICS INC | 55910K108 | 550,000 | $416,900 | 0.06% |
| 40 | INOZYME PHARMA INC | 45790W108 | 49,702 | $276,840 | 0.04% |
| 41 | MONTE ROSA THERAPEUTICS INC | GLUE | 19,900 | $136,315 | 0.02% |